Posted by Michael Wonder on 10 Mar 2021
NICE finally publishes final guidance for Aimovig
10 March 2021 - Erenumab has been recommended by NICE for certain patients with migraine.
Erenumab is recommended as an option for the prevention of migraine in adults, only if:
- They have 4 or more migraine days a month
- At least 3 preventive drug treatments have failed
- The 140 mg dose of erenumab is used
Of course, erenumab is only recommended if Novartis complies with the commercial arrangement
